← Back to Clinical Trials
Recruiting NCT07485621

NCT07485621 LFP-based Parameter Prediction in DBS for Parkinson's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07485621
Status Recruiting
Phase
Sponsor Loes Laurijssen
Condition Parkinson's Disease (PD)
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2026-03-05
Primary Completion 2029-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2026-03-05 with a primary completion date of 2029-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to assess whether deep brain stimulation (DBS) contact selection in Parkinson's disease could be informed by subcortical local field potential (LFP) recordings. The main question it aims to answer is: Aligns stimulation contact selection based on subcortical LFP recordings with clinically optimized contact selection? Participants will undergo LFP recordings that are part of standard clinical care during their routine hospital visits.

Eligibility Criteria

Inclusion Criteria: 1. Voluntary written informed consent of the participant 2. At least 18 years of age at the time of signing the Informed Consent Form (ICF) 3. Diagnosis of idiopathic Parkinson's disease according to the clinical diagnostic criteria of the Movement Disorder Society (MDS) 4. Eligible for DBS to treat refractory PD motor symptoms, as based on multidisciplinary DBS screening 5. Have sufficient understanding of the Dutch and French language to participate in the study Exclusion Criteria: * /

Contact & Investigator

Central Contact

Bart Swinnen, MD, PhD

✉ bart.swinnen@uzleuven.be

📞 0032 16343044

Frequently Asked Questions

Who can join the NCT07485621 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Parkinson's Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07485621 currently recruiting?

Yes, NCT07485621 is actively recruiting participants. Contact the research team at bart.swinnen@uzleuven.be for enrollment information.

Where is the NCT07485621 trial being conducted?

This trial is being conducted at Leuven, Belgium.

Who is sponsoring the NCT07485621 clinical trial?

NCT07485621 is sponsored by Loes Laurijssen. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology